New publication – Diabetes Cost-Benefit Assessment in Saudi Arabia
An innovative Cost-Benefit assessment of a nutrition solution in Diabetes in Saudi Arabia.
New publication – Fertility Cost Effectiveness of IVF for PCOS patients in Italy
A Markov‑model simulation of IVF programs for PCOS patients indicates that
coupling myo‑Inositol with rFSH is cost‑effective for the Italian Health System.
ISPOR 2022 : Are we capturing the multidimensional value of rare disease therapies through the QALY?
At the ISPOR Conference in Washington DC, USA on May 2022,
Dr. Ariel Beresniak represented Data Mining International in the Expert Panel alongside :
Dr. Alicia Granados of Sanofi, Michael Drummond Professor of Health Economics at York University, Sheela Upadhyaya Expert in Rare Diseases and ISPOR Chair Elect, Durhane Wong-Rieger President of the Canadian Organization for Rare Disorders, and Karen Facey who chaired the panel.
Thank you to panellists of ISPOR2022 in Washington for their insights shared in this Issue Panel Report, including :
▶️ Alicia Granados, MD, PhD PH says small, heterogeneous populations showing […]
DMI Pandemic Preparedness Framework at ICEID 2022
Data Mining International is proud to announce that the results of an ambitious project in collaboration with the WHO Headquarters, will be presented at
the 11th International Conference on Emerging Infectious Disease (ICEID 2022)
in Atlanta from 7th-10th August 2022.
The Congress is hosted by the Centers for Disease Control and Prevention in collaboration with the Task Force for Global Health, bringing together more than 1500 public health professionals from around the world to encourage the exchange […]
DMI – partners of REMEDIA European Commission research on Exposome
Data Mining International are partners of the European Commission REMEDIA project, which aims to determine how and to what extent the Exposome affects our health and causes disease.
Throughout our life, we are exposed to a variety of factors, which are a function of our lifestyle, behavior and environment, and which all have impacts on our health. All of these exposures form a concept called “the exposome”.
The REMEDIA research will help to detect the most influent exposome components on the development and outcomes of lung diseases throughout life. REMEDIA […]
Brevets des vaccins anti-Covid : l’arbre qui cache la forêt
In this article, Ariel Beresniak – CEO of Data Mining International – recalls some points to consider as to whether Patents for Covid-19 vaccinations should be lifted as is currently suggested by the United States.
Link to the article (French)
Brevets des vaccins anti-Covid : l’arbre qui cache la forêt
Press release : Cosmetic products improve quality of life and it is measurable
A new short version of the measuring instrument BeautyQol has been specifically developed to enable the scientific demonstration that cosmetic products and good physical appearance improve the quality of life.
GENEVA, SWITZERLAND (PRWEB) MARCH 19, 2021
The BeautyQol questionnaire was developed in 13 countries (France, the United Kingdom, Germany, Spain, Sweden, Italy, Russia, the United States, Brazil, Japan, India, China, and South Africa) and validated in 16 languages for measuring how cosmetic products and good physical appearance improve Quality of Life (QoL). While the original version contained 42 questions to assess 5 dimensions of QoL, the new BeautyQol […]
Vaccin contre le Covid-19 : le pari de Pascal du gouvernement
As public health authorities prepare for the implementation of their vaccination programmes to stop the Covid-19 pandemic, Dr. Ariel Beresniak lays out some of the fundamental reasons for the population’s lack of faith in the new vaccines – challenging Pascal’s bet that it is wiser to have faith in God than not to.
Link to the article
Vaccin contre le Covid-19 : le paris de Pascal du gouvernement
Confinement : “Une mauvaise stratégie” – Interview de Dr Ariel Beresniak
Amid the Covid-19 crisis, Dr. Ariel Beresniak was interviewed by Corse Matin on the value of confinement as public health strategy.
Link to the interview
Confinement : “Une mauvaise stratégie”